Journal of Cancer Clinical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-7360-538437

About The Journal Open Access

Journal of Cancer Clinical Research

Journal of Cancer Clinical Research is a peer reviewed, open access periodical dedicated to publish the clinical advancements in the cancer research and therapy providing end-to-end solutions, from diagnosis thorough various stages of cancer therapy, pharmaceutical advancements, drug delivery, clinical trials, rehabilitation and care. Journal of Cancer Clinical Research provides a forum for the exchange of information on all aspects related to cancer diagnosis and therapy by including expert’s opinions as editorials.

You may submit manuscripts online at https://www.scholarscentral.org/submissions/cancer-clinical-research.html or you may send the article as an email attachment to the following mail-id: [email protected].

Individuals interested in becoming members of the Editorial/Review Board should contact by email.

Fast Editorial Execution and Review Process (FEE-Review Process):

Journal of cancer clinical research is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.

Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.

The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.

Please submit your manuscript to
[email protected]

Just Published Articles View More

Mini Review October 06, 2022

P.1-2

J Cancer Clin Res: 5(4): 1-2

Neoadjuvant therapy pancreatic cancer& breast cancer meta-analysis of randomized controlled trials

Melissa Ferraro

DOI:

Rapid Communication October 06, 2022

P.1-2

J Cancer Clin Res: 5(4): 1-2

Mutations of melanoma on cholecystokinin receptor antagonist by inducing apoptosis of tumor cells

Richard Andrew

DOI:

Short Communication October 06, 2022

P.1-2

J Cancer Clin Res: 5(4): 1-2

Validation of a novel apoptosis chemotherapeutic drugs effect of osteosarcoma metastasis

Zhang Liu

DOI:

Mini Review October 06, 2022

P.1-2

J Cancer Clin Res: 5(4): 1-2

Molecular signatures exposure of childhood retinoblastoma tumors

Josephine Saskia

DOI:

Perspective October 06, 2022

P.1-2

J Cancer Clin Res: 5(4): 1-2

A pilot study of barriers to interventional radiology for hepatocellular carcinoma.

Sherry Osinski

DOI:

Opinion Article June 25, 2022

P.1-2

J Cancer Clin Res: 5(3): 1-2

Correlation between pathologic tumors and granular cell tumors.

Stephen Thomas

DOI:

Relevant Topics

Get the App